Cargando…

DNA Nanodevice-Based Drug Delivery Systems

DNA, a natural biological material, has become an ideal choice for biomedical applications, mainly owing to its good biocompatibility, ease of synthesis, modifiability, and especially programmability. In recent years, with the deepening of the understanding of the physical and chemical properties of...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Chaoyang, Zhu, Xiaoli, Feng, Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699395/
https://www.ncbi.nlm.nih.gov/pubmed/34944499
http://dx.doi.org/10.3390/biom11121855
_version_ 1784620503295590400
author Guan, Chaoyang
Zhu, Xiaoli
Feng, Chang
author_facet Guan, Chaoyang
Zhu, Xiaoli
Feng, Chang
author_sort Guan, Chaoyang
collection PubMed
description DNA, a natural biological material, has become an ideal choice for biomedical applications, mainly owing to its good biocompatibility, ease of synthesis, modifiability, and especially programmability. In recent years, with the deepening of the understanding of the physical and chemical properties of DNA and the continuous advancement of DNA synthesis and modification technology, the biomedical applications based on DNA materials have been upgraded to version 2.0: through elaborate design and fabrication of smart-responsive DNA nanodevices, they can respond to external or internal physical or chemical stimuli so as to smartly perform certain specific functions. For tumor treatment, this advancement provides a new way to solve the problems of precise targeting, controllable release, and controllable elimination of drugs to a certain extent. Here, we review the progress of related fields over the past decade, and provide prospects for possible future development directions.
format Online
Article
Text
id pubmed-8699395
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86993952021-12-24 DNA Nanodevice-Based Drug Delivery Systems Guan, Chaoyang Zhu, Xiaoli Feng, Chang Biomolecules Review DNA, a natural biological material, has become an ideal choice for biomedical applications, mainly owing to its good biocompatibility, ease of synthesis, modifiability, and especially programmability. In recent years, with the deepening of the understanding of the physical and chemical properties of DNA and the continuous advancement of DNA synthesis and modification technology, the biomedical applications based on DNA materials have been upgraded to version 2.0: through elaborate design and fabrication of smart-responsive DNA nanodevices, they can respond to external or internal physical or chemical stimuli so as to smartly perform certain specific functions. For tumor treatment, this advancement provides a new way to solve the problems of precise targeting, controllable release, and controllable elimination of drugs to a certain extent. Here, we review the progress of related fields over the past decade, and provide prospects for possible future development directions. MDPI 2021-12-10 /pmc/articles/PMC8699395/ /pubmed/34944499 http://dx.doi.org/10.3390/biom11121855 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Guan, Chaoyang
Zhu, Xiaoli
Feng, Chang
DNA Nanodevice-Based Drug Delivery Systems
title DNA Nanodevice-Based Drug Delivery Systems
title_full DNA Nanodevice-Based Drug Delivery Systems
title_fullStr DNA Nanodevice-Based Drug Delivery Systems
title_full_unstemmed DNA Nanodevice-Based Drug Delivery Systems
title_short DNA Nanodevice-Based Drug Delivery Systems
title_sort dna nanodevice-based drug delivery systems
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699395/
https://www.ncbi.nlm.nih.gov/pubmed/34944499
http://dx.doi.org/10.3390/biom11121855
work_keys_str_mv AT guanchaoyang dnananodevicebaseddrugdeliverysystems
AT zhuxiaoli dnananodevicebaseddrugdeliverysystems
AT fengchang dnananodevicebaseddrugdeliverysystems